Purolite and Repligen to commercially launch novel CH1 affin

Ion exchange resin manufacturer Purolite and bioprocessing technology firm Repligen have announced the commercial launch of Praesto CH1, an affinity resin designed to purify specialized mAbs such as bispecifics and recombinant antibody fragments.

Related Keywords

Landenberg , Pennsylvania , United States , Jennifer Sorrells , Ralf Kuriyel , , Markets Amp Regulations , Pipelines , Emerging Markets , Purolite , Esin , Bioprocessing , Bispecific Antibodies , Manufacturing , Iologics ,